LIG & Co. actively targets businesses that we believe play a crucial role in addressing the evolving needs of the healthcare system. Our emphasis is on those entities dedicated to enhancing patient outcomes, eliminating superfluous costs, improving overall efficiency, and aligning incentives for all stakeholders involved. We strategically navigate the major verticals of the industry, focusing on companies operating in the pharmaceutical, medical device, provider services, and healthcare insurance sub-sectors.
In the realm of healthcare growth equity, our commitment is unwavering. Core to our healthcare strategy is the identification and investment in companies that contribute tangible value within the healthcare system. For us, value is defined as "health outcomes achieved per dollar spent." Every company we choose to invest in must demonstrate a commitment to either improving health outcomes, lowering costs, or ideally, achieving both simultaneously.
Moreover, our approach involves not just identifying potential within the healthcare sector but also actively participating in the growth and transformation of these businesses. We collaborate closely with management teams, leveraging our industry expertise and resources to support companies in realizing their full potential.
At LIG & Co., we believe that a focus on value-driven healthcare investments is not only financially sound but also aligns with the broader goal of advancing the overall well-being of individuals and communities. Our commitment to healthcare growth equity extends beyond traditional financial metrics, encompassing a broader vision of creating meaningful and positive impacts within the healthcare landscape.